Tandem Health Secures $46 Million Funding Round

Tandem Health has secured $50 million in Series A funding led by Kinnevik, with participation from Northzone, Amino Collective, and Visionaries Club. The company plans to use the investment to accelerate development of an AI-native operating system for clinical workflows across Europe.

Tandem’s AI assistant helps clinicians create accurate, compliant medical notes automatically as they speak with patients, eliminating the need for typing or dictation. Through a partnership with Accurx, more than 200,000 NHS professionals in the UK already have access to Tandem’s technology, marking one of the largest healthcare AI deployments globally.

The company’s vision extends beyond documentation. With this funding, Tandem aims to build tools that capture clinical codes, coordinate care, and support clinical decisions at the point of need. Their goal is not to replace clinicians but to remove friction so healthcare workers can focus more fully on patient care.

Founded in the Nordics, Tandem now operates in the UK, Germany, France, and Spain. The team includes over 20 doctors and psychologists working alongside hundreds of healthcare organizations to tailor the platform to each country’s needs. Tandem believes the future of healthcare depends on enabling clinicians to spend time on the work only humans can do.

Competitors in the ambient clinical documentation and workflow automation space include Microsoft’s Nuance DAX Copilot, Abridge, Suki AI, DeepScribe, Ambience Healthcare, Nabla Copilot, Heidi Health, Corti, Tortus, and Augmedix, all of which provide AI systems that listen to clinician-patient conversations and convert them into structured medical notes while integrating with major electronic health-record platforms. Tandem Health differentiates itself by targeting Europe’s multilingual, GDPR-bound markets and by expanding its product into a full AI-native operating system that also handles coding, care coordination, and real-time decision support.